政策不可预期,真正撬动处方药格局变化的力量,依然来自从下而上的倒逼,是药店端和工业端的合力。万亿规模的中国药品市场中,处方药占八成,其中零售渠道只占到20%。这20%已经殊为不易,在药品分类管理要求凭处方购买处方药的政策下,医院严防死守处方,厂商资源更多投在销量大的医院渠道,药店难有更大作为。近期一份文件的发布,使这一局面有望破冰。9月9日,商务部等六部门发布一份名为《关于落实2014 Unpredictable policy, the real leverage to change the power of prescription drugs, still comes from the bottom up force, is the pharmacy and industrial end of the force. In the trillion-scale Chinese pharmaceutical market, prescription drugs account for 80% of the total, of which retail channels account for only 20%. This 20% has been particularly hard-won, under the policy of requiring drug prescriptions to be prescribed by prescriptions, the hospital strictly guard against prescribing prescriptions and the manufacturer resources are more invested in large-selling hospital channels. The release of a recent document is expected to make the situation more icy. On September 9, six departments such as the Ministry of Commerce issued a document entitled "Implementation of 2014